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Summary 
Activation of T helper cell 1 (Thl) and Th2 results in transcription  of the interleukin 2 (IL-2) 
and IL-4 cytokine genes, respectively. Whereas many of the regulatory elements  and factors 
responsible for IL-2 transcription in T cells are well defined, little is known about parallel mechanisms 
that drive transcription  of the IL-4 gene. Here we have analyzed the murine IL-4 promoter, 
both in vivo and in a Th2 clone. 3 kh of IL-4 upstream sequence is shown to be sufficient to 
achieve tissue-specific and inducible expression of a thymidine kinase reporter gene in vivo in 
a manner that mirrors the expression of  endogenous IL-4. Tissue-specific  and inducible expression 
is also demonstrated in a Th2 done, but not in a B cell line. Deletional and mutational analysis 
of the IL-4 promoter demonstrated that sequences from  -100 to  -28 were necessary for a 
transcriptional response to Concanavalin A or anti-CD3 monoclonal antibody. An overlapping, 
yet smaller region, spanning  the sequences from  -60 to  -28 bp was shown to be required 
for the response to ionomycin. Mutation of an 8-bp region from - 43 to - 35 of the IL-4 promoter 
completely abrogated IL-4 gene transcription  in response to all stimuli tested. In addition,  our 
results show that the effects of the immunosuppressive agent Cyclosporin A map to the same 
DNA sequences as the positive control elements. These results identify DNA sequences that 
are functionally important for the control of IL-4 gene transcription both in vivo and in vitro. 
Although these sequences are highly conserved in the human and murine IL-4 genes, they are 
largely not present  in the IL-2 enhancer complex.  Thus, cytokine-specific cis-acting  elements 
may be one mechanism by which these two cytokine genes are differentially regulated. 
T 
he interaction of Th cells with peptide-MHC complexes 
on APCs,  initiates a cascade of events culminating in 
an effective immune response. One consequence of this in- 
teraction is the synthesis and release of cytokines into the 
surrounding microenvironment. One such cytokine,  IL-4, 
originally described as a B lymphocyte  growth factor, is now 
known to regulate a broad spectrum of biologic  activities 
including activation,  growth and differentiation  of T lym- 
phocytes, B lymphocytes, macrophages, and cells of the inflam- 
matory and hematopoietic systems (1, 2). The receptor for 
IL-4 is expressed  on most cells of hematopoietic lineage, where 
it can be regulated  in an autocrine manner (3, 4). 
Subsets of murine CD4 + Th cells have been defined on 
the basis of their ability to provide help to B ceils and on 
the patterns of their cytokine secretion (5-7). The Thl-type 
clones dassicaUy  produce IL-2, TNF, lymphotoxin, and IFN-'y 
and participate in delayed-type  hypersensitivity responses. Th2 
calls, on the other hand, secrete IL-4,  -5,  -6 and -10, and 
provide help to B cells. Both Thl and Th2 cells secrete GM- 
CSF  and IL-3.  Thus,  whereas  there is  some overlapping 
cytokine secretion between these subsets of cells, it appears 
that among differentiated Th populations, Thl cells produce 
IL-2 and Th2 cells produce IL-4. One mechanism by which 
differential expression of IL-2 and IL-4 in vivo is accomplished 
may involve differences in DNA sequence elements in the 
two promoters. Dissection of the II,-2 promoter had identified 
several functional elements including those that bind nuclear 
factor  of activated T  cells (NFAT)  1,  NFIL-2,  and NF-IcB 
(8-10). These elements, with the exception of the NFAT se- 
quence, are not present in the IL-4 promoter sequence. An- 
other mechanism may involve alternative T  cell activation 
pathways that can differentially regulate transcription factors 
that bind the IL-2 and IL-4 promoters in Thl versus Th2 
cells (11, 12). 
In this report, we describe the analysis of the murine IL-4 
promoter. We demonstrate that "~3 kb of the IL-4 promoter 
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in vivo. In a Th2 clone, we demonstrate that the first 97 bp 
of the IL-4 promoter is sufficient to mediate induction from 
two distinct pathways initiated at the cell surface.  Linker- 
scanning mutagenesis and multimerization experiments fur- 
ther localize response elements to several  discrete regions within 
this proximal promoter. This control region is highly con- 
served between murine and human IL-4 promoters. Very little 
homology, however, is noted between this region of the IL-4 
promoter and the well-characterized IL-2 enhancer-promoter 
complex with the exception of an NFAT-like sequence. Our 
data also suggest that Cyclosporin A (CsA) downregulates 
IL-4 gene transcription by inhibiting the function of the posi- 
tive elements. 
Materials and Methods 
Cell Lines.  D10 cells were grown in RPMI 1640 medium sup- 
plemented with 10% rat Con A supernatant,  10% FCS, 2 mM 
glutamine, 100/~M nonessential amino acids, 1 mM sodium pyru- 
vate, 100/~g/ml  penicillin and streptomycin, and 10-4 M 2-ME. 
All  other cell lines were grown in  RPMI  1640 medium  sup- 
plemented with 8% FCS, 2 mM glutamine, 100/~g/ml penicillin 
and streptomycin, and 10 -4 M 2-ME. D10 is a murine Th2 clone 
specific for conalbumin in the context of I-A  ~ (13). EL4 cells were 
derived from a murine thymoma and M12.4.1 cells were derived 
from a mature B cell lymphoma. 
Transgenic Mice.  A BgllI fragment containing '~3 kb (-3 kb 
to + 58 bp) of Ib4 upstream sequence, derived from a routine Ib4 
genomic clone isolated from a C57BL/6 spleen cell library, was 
fused to the coding region of the HSV thymidine kinase (tk) gene. 
Using  standard  techniques,  this  fusion  construct  was  injected 
into (CBA/J  x  C57BL/6)F1 and transgenic  animals from one 
founder line containing 5-10 copies of the transgene established 
(14). The mice were then bred to achieve homozygous expression 
of the transgene. 
PCR Analysis oflb4 mRNA.  Total tissue RNA was isolated 
from one mouse by methods previously described (15). cDNA syn- 
thesis was performed with 5 #g of total DNase-treated RNA in 
lx Superscript buffer (GIBCO BILL, Gaithersburg, MD), 10 mM 
DTT, and 300/zM of each dNTP, 1.5/zM oligo(dT), and 200 U 
Superscript-reverse transcriptase  (GIBCO BILL). The reaction 
volume was 20/zl. After incubation at 42~  for 1 h, the oligo(dT) 
was  removed using  a G-50 column  (Worthington Biochemical 
Corp., Freehold, NJ); the total volume was 50/zl. A mock reac- 
tion lacking reverse  transcriptase was prepared as a negative control. 
15 #1 of the cDNA reaction mixture was serially diluted from 1:10 
to 1:320. The negative control was diluted 1:10. 10/zl of  each cD.NA 
dilution was used for a PCtL in lx  Taq buffer (Boehringer Mann- 
helm Biochemica, Indianapolis, IN), 300/~M each dNTP, 25 pmol 
of  each primer, and 2.5 U Taq DNA polymerase  (Boehringer Mann- 
heim Biochemica). The reaction volume was 50/zl. 25 cycles for 
hypoxanthine phosphoribosyl transferase  (HPRT) primers, 30 cycles 
for IL-4  primers, and 35 cycles  for Ib4/tk primers were performed 
for 1 min at 95~  2 rain at 59~  and 3 rain at 72~  (10 min 
1  Abbreviations used in this  lmper: CAT, chloroamphenicol  acetyl  transferase; 
CsA, Cyclosporin  A; HPRT, hypoxanthine  phosphoribosyl transferase; 
NFAT, nuclear factor of activated T cells; tk, thymidine kinase. 
during the last cycle). Primers for the fusion gene consisted of a 
5' primer in the IL-4 gene 5' untranslated region and a 3' primer 
in the tk gene. Sequences of PCIL primers specific for the II.,4, 
tk, and HPRT cDNA are available  upon request. 8/~1 of each PCR 
reaction was electrophoresed  on a 4% agarose  gel denatured in 0.5 M 
NaOH, 0.8 M NaCI, neutralized in 0.5 M Tris (pH 7.6), 1.5 M 
NaC1, and Southern blotted onto GeneScreen  membrane (New En- 
gland Nuclear, Boston, MA). Southern hybridization  was performed 
as described (15). The probe for I1.-4 was a 373-bp EcoRI/HindlII 
fragment from the IL-4  cDNA (gift from W. Paul, National Insti- 
tutes of Health, Bethesda, MD). The HSV-tk plasmid was a kind 
gift of R. Evans (Massachusetts General Hospital, Boston, MA). 
The probe for tk was an "~450-bp Xbal/SphI fragment and the 
probe for HPRT was a PCR product made from cDNA with the 
same primers as those used in the experimental PCR reactions. 
Stimulation of  Primary T Cells.  LN were collected  from five  trans- 
genic mice, reduced to a single cell suspension and plated onto an 
anti-CD3 mAb (2Cll) coated dish in RPMI media (GIBCO BRL) 
with 10% FCS, 100 mM glutamine, 100/~g/ml penicillin and strep- 
tomycin, and 10 -4 M 2-ME. 200 U/ml rlL-2 and 500 U/ml IL-4 
(J558L supernatant from cells transfected with the IL4 cDNA, gift 
of Dr. R. Tepper, Massachusetts General Hospital, Boston, MA) 
were added to the cell cultures. The cells were stimulated for 24 h, 
lysed with guanidinium isothiocyanate, and prepared for PCR as 
above. As an unstimulated control, transgenic LN RNA was made 
directly from fresh tissue. 
Plasmids and Mutagenesis.  Standard recombinant technology was 
used (15). Numbering of IL-4 gene sequences designates +1 as the 
start of transcription  as described by Otsuka et al. (16). A 3-kb 
fragment of the IL-4 5' untranslated region (,~ -3 kb to  + 58 bp) 
was derived from a BgllI digestion of subcloned genomic sequences, 
blunted, and subcloned into the end-filled  HindlII site of  pSVOcatA 
(a gift ofJ. Strominger, Harvard University, Boston, MA). The 
801-bp fragment (spanning 5' noncoding sequences from - 801 to 
+ 58 bp) was a BgllI/HindlII fragment, blunted,  and subdoned 
into pSVOcatA, pSVOcatA contains the chloramphenicol acetyl 
transferase (CAT) gene but no promoter or enhancer sequences. 
Deletion mutations of the IL-4  promoter were generated by using 
PCIL to amplify appropriate sequences. In each case, a SalI site was 
introduced at the 5' end and a XbaI site was added at the invariant 
3' end. Substitution mutations of the IL-4 promoter were created 
using PCR to amplify two DNA fragments which, when cut with 
SalI and BgllI or XbaI and BgllI and ligated, reconstitute the IL-4 
promoter sequences -157 to +58 with the appropriate base sub- 
stitutions. The fragments were subdoned into pSVOcatApoly (the 
pSVOcatA plasmid containing a polylinker  with SalI and XbaI sites). 
The nudeotide sequences of both strands were confirmed using 
the dideoxynucleotide method with Sequenase, as recommended 
by the manufacturer  (U.S. Biochemical Corp.,  Cleveland, OH). 
20-bp sequences of  interest were multimerized with six random 
bases inserted between three repeats. These sequences were made 
into two complementary oligonudeotides  with BamHI sites on 
the end. The oligonudeotides were kinased and then annealed. The 
multimer fragments were ligated into the BamHI site of  pBLCAT2 
which contains the tk promoter linked to the CAT reporter gene. 
All plasmids were sequenced as described. 
Transfection.  D10 and EL4 cells were transfected by electropo- 
ration using a Gene Pulsar (Bio-Rad Laboratories,  Richmond, CA). 
20/~g of plasmid DNA were added to 107 cells in 400/~1 of RMPI 
1640 medium in a 0.4-cm gap electroporation cuvette (Bio-Rad 
Laboratories) and incubated for 10 rain at room temperature. Cells 
were electroporated at 270 V, 960/zF with an average time con- 
stant of 25. The cells were then placed on ice for 10 min and cul- 
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transfection, D10 cells were stimulated with 10 #g/ml Con A (Sigma 
Chemical  Co.,  St.  Louis, MO),  1 #M ionomycin  (Calbiochem 
Corp., La JoUa, CA), or on an anti-CD3  mAb coated plate at 100 
#g/ml, or incubated with 1 #g/ml CsA (gift from A. Abbas, Har- 
vard Medical School) for 16-18 h. Protein extracts were prepared 
and CAT activity was assayed  and quantitated using thin layer chro- 
matography  and  liquid  scintillation  counting  as described (15). 
M12.4.1 cells were transfected using  the DEAE-dextran  method 
as described (15). 10 #g of plasmid DNA were transfected into 
M12.4.1. cells, and 24 h after transfection,  the cells were stimu- 
lated with I #M ionomycin for 16-18 h. Cells were harvested and 
CAT activity assayed  as  described above. 
Results 
Approximately 3 kb of  S' IL-4 Upstream Sequence is Su.~cient 
for  Tissue-Specific and  Inducible Expression In  Vivo and  In 
Vitr~  IL-4 expression is both strictly tissue limited and highly 
inducible after T call-activating stimuli (2). SpecificaUy, IL- 
4 expression is limited to a subset of T  helper ceils  (Th2), 
to mast cells, and to a non-T-non-B cell population in spleen 
and bone marrow (17).  To determine whether sequences 5' 
to  the  IL-4  coding  region  were  sufficient  for  in  vivo 
tissue-specific  and inducible expression, a murine IL-4 genomic 
clone containing  "o7 kb of 5' sequence was isolated from a 
mouse spleen genomic library. A line of mice was generated 
that contains a transgene consisting of "o3 kb of IL-4 5' se- 
quence fused to the herpes virus tk gene. Appropriate breeding 
led to the production  of a transgenic  line homozygous for 
the  IL-4  tk  transgene. 
Immune (thymus, spleen, and LN) and nonimmune (kidney, 
liver,  and heart)  tissues were harvested from these mice and 
RNA prepared. Since levels of endogenous IL-4 are extremely 
low in freshly isolated, unstimulated T ceils (18), organ RNA 
was used to generate first-strand  cDNA and comparative PCR 
using primers specific for IL-4 or IL-4 tk sequences was per- 
formed. Hybridization of amplified PCK products to an IL-4 
or tk-specific probe revealed a single band of the correct size 
in the lanes containing thymus, LN, and spleen (Fig.  1 A). 
No hybridization was seen to liver,  kidney, or heart (Fig.  1 
A). All sample dilutions were approximately equal as demon- 
strated by the equivalent amount of PCR product obtained 
when control primers to HPKT were used (data not shown). 
We conclude that 3 kb of the IL-4 promoter is sufficient to 
drive tissue-specific expression in a manner  which parallels 
endogenous  IL-4 expression in vivo. 
We next performed experiments  to determine if 3 kb of 
the IL-4 promoter contained elements responsive to T  cell 
activation stimuli in vivo. LN cells from IL-4 tk mice were 
plated in tissue culture dishes coated with anti-CD3  mAb, 
and RNA was prepared after culture for 24 h.  This RNA 
was utilized as described above to produce cDNA which was 
then used in comparative PCR and probed with IL-4 or tk- 
specific probes. These samples were compared with samples 
that had not been stimulated with anti-CD3 mAb. In all cases, 
there was at least 10-fold increase in the amount of IL-4 tk 
message seen when the cells were exposed to activating anti- 
CD3 mAb (Fig. 1 B). The induction of IL-4 tk message par- 
alleled  induction  of endogenous  IL-4  message  (Fig.  1 B). 
Therefore, 3 kb of IL-4 promoter contains sequences respon- 
sive  to  T  cell activation  stimuli  in vivo. 
To begin to dissect functionally important elements in the 
IL-4 promoter, we next examined the expression of IL-4 pro- 
motet sequences in vitro. IL-4 promoter sequences containing 
,o3 kb, 801 bp and 157 bp of upstream sequence were fused 
to the bacterial CAT reporter gene in the vector pSVOcatA. 
pSVOcatA contains the bacterial CAT gene and SV40 poly- 
adenylation  sequences, but  no exogenous promoter  or en- 
hancer sequences. Promoter activity was measured by trans- 
fecting the IL4-3kb, IL4-801,  and IL4-157 plasmid constructs 
(Fig.  2 A)  into  the well-characterized  Th2  clone,  D10,  or 
into the thymic lymphomas cell line,  EL4. Both of these cell 
Figure 1.  Tissue-specific and inducible  regulation of 
IL-4 5' sequences in vivo. Immune and nonimmune tissue 
RNA was harvested from transgenic  mice homozygous 
for a construct containing ,x,3 kb of the IL-4 promoter 
fused to the bacterial tk gene. First-strand cDNA was syn- 
thesized and serially diluted from 1:10 to 1:320 and used 
in comparative PCR. Only the 1:10 dilution was used for 
the nonimmune tissues. A negative control (CTRL) con- 
raining a 1:10 dilution of RNA was included for each tissue. 
Primers  specific for the endogenous  IL-4 mRNA or for 
the Ib4 tk fusion  RNA were used to generate  specific 
products  of 180 and 250 bp, respectively. PCR products 
were  electrophoresed  on  a  4%  agarose  gel  and  then 
Southern blotted. The blots were hybridized using either 
a probe specific  for ID4 or for tk DNA product.  (A) Com- 
parative PCK ofunstimuhted immune (thymus, lymph node, 
spleen) and nonimmune (heart, hid., liver) mRNAs using 
probes  specific for endogenous  ID4 or tk messages. (B) 
Comparative PCR of unstimulated  LN mRNA vs anti- 
CD3 stimulated LN mRNA using probes specific for en- 
dogenous Ib4 or tk messages. 
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of the plL4-3kb, pIL4-801,  and plL4-157 reporter constructs containing 
ID4 promoter sequences subcloned into the vector pSVOCATA. (B) EL4 
thymoma cells were transfected with reporter constructs and appropriate 
samples were treated with 1 #M ionomycin beginning 24 h after transfec- 
tion. Cells were harvested 48 h after transfection and CAT activity assayed 
by thin layer chromatography and liquid scintillation counting. (C) The 
Th2 clone D10 was transfected  with the reporter constructs and stimu- 
lated with 1/~M ionomycin. (/9) M12.4.1 cells were transfected with the 
reporter constructs and stimulated as above. A representative experiment 
is shown. At least three independent experiments were conducted for each 
cell line. (NA) No significant  induction of CAT activity generated by 
pSVOCATA  or pCAT-Control. 
lines  produce IL-4 after stimulation with T  cell  activation 
agents such as anti-CD3 mAb, Con A,  or ionomycin, but 
produce minimal IL-4 at baseline. A transformed B cell line, 
M12, which expresses no endogenous IL-4 was used as a nega- 
tive control. After transfection, the cells were cultured in the 
presence  or  absence  of the  calcium  ionophore,  ionomycin, 
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chosen as an inducing  stimulus since M12 ceUs do not ex- 
press surface CD3 or TCR. Cell lysates were then prepared 
and the percent conversion of acetylated chloramphenicol was 
quantitated  by thin  layer chromatography. 
In D10 cells, an ~15-fold induction was seen above back- 
ground (Fig. 2 C) and in EL4 cells, an "~sevenfold induction 
was seen with the constructs after stimulation with ionomycin 
(Fig.  2 B). Transfection of these constructs into the B cell 
lymphoma M12 did not yield higher levels of CAT activity 
than that seen with the CAT vector alone (Fig. 2 D). Also, 
no expression was detected in the Thl done, D1.1 (Lederer, 
J., M. D. Todd, L. H. Glimcher, and A. H. Lichtman, manu- 
script in preparation).  We condude that  157 bp of the IL-4 
promoter is suftident to confer ionomycin-induced and tissue- 
specific  expression in vitro. 
Deletional Analysis Maps Inducible Promoter Activity to a Re- 
gion Either 3' of -97 or 3' of -77 bp.  To further identify 
DNA sequences in the IL-4 promoter involved in inducible 
activity,  a  series  of 20-bp  deletions  was made  starting  at 
-157-bp upstream and ending at  -77-bp upstream and the 
resulting fragments cloned into the pSVOcatA vector. Dele- 
tion constructs were transfected into D10 cells, and ceils were 
stimulated for 24 h to induce IL-4 gene transcription. Several 
different stimuli were used to induce IL-4 transcription these 
including  Con A,  anti-CD3  mAb,  and ionomycin. 
D10 cells were stimulated with  10 #g/ml  of Con A  or 
plate-bound anti-CD3 mAb for 24 h after transfection of the 
deletion  constructs.  Con  A  and  anti-CD3  mAb  are both 
thought  to act through  the TCR-CD3  complex.  In these 
experiments, Con A or anti-CD3 treatment led to an average 
fivefold induction of all deletion constructs 5' to and including 
plL4-97 (Fig. 3, A  and B). Activity decreased to ~l.5-fold 
or lower from pIL4-97 to pIL4-77 (Fig.  3, A  and B). The 
CAT activity of the IL4-77 construct in Con A or anti-CD3 
treated cells dropped off to uninduced levels (Fig.  3, A  and 
B). From these results we conclude that ddetion of the region 
from -97 to -77 of the IL-4 promoter perturbs Con A/anti- 
CD3  mAb-mediated  stimulation  of the IL-4 gene. 
Another stimulus that can induce IL-4 gene transcription 
in D10 cells is ionomycin. Ionomycin is a calcium ionophore 
that allows influx of extraceUular calcium into a cell.  Classi- 
cally, calcium ionophores are used in conjunction with pro- 
tein kinase (PKC) activators such as PMA to activate T cells. 
In initial experiments, however, ionomycin alone worked as 
weU as ionomycin plus PMA to activate IL-4 gene transcrip- 
tion in our subclone of D10 cells. D10 cells were therefore 
stimulated with 1/~M ionomycin alone after transfection with 
the deletion constructs.  Ionomycin induced IL-4 gene tran- 
scription an average of 15-fold over basal activity in D10 calls 
using the ddetion constructs from IL4-157 to IL4-77 (Fig.  3, 
A  and B). When cells were treated with DMSO (the vehicle 
for ionomycin) alone, no activation of the IL-4 promoter was 
seen (data not shown). Therefore, the sequences 3' of -77 
bp  must  contain  an  element(s)  that  is  responsive  to  the 
ionomycin induction  pathway. 
The immunosuppressive drug,  CsA, prevents IL-2 gene 
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mconA 
Anti CD3 
F'I  Ionomycin 
D  CsA + IOno 
m  ~  +  C.ori  A 
plL4-97 
IL-4 Promoter Deletions 
plL4-77 
Effects of deletion on inducible expression of IL-4 promoter 
plasmids in DIO calls. (/1) Structure of constructs containing progressive 
deletions of 5' flanking Ib4 sequence. D10 cells  were transfected  with pro- 
motet plasmids and 24 h hter stimulated with 10 #g/ml Con A, anti- 
CD3 coated plates, 1/~M ionomycin or 1/~M ionomycin plus 1/~g/ml 
CsA. CAT activity  was assayed  48 h after transfection. Each plasmid was 
assayed in at least three independent transfections. The data is shown as 
mean fold induction _+ SE. Fold  induction was calculated as induced per- 
cent conversion divided by uninduced percent conversion. The absolute 
percent conversion was in the range of 2-15  %. (*) Mean fold inductions 
calculated from two experiments where SE not shown. (B) Fold  induction 
generated by deletion mutations using Con A, anti-CD3, ionomycin, 
ionomycin plus CsA, or Con A plus CsA. 
transcription by interfering with T cell activation pathways 
(19).  Recently, it has been shown that CsA interferes with 
IL-2  gene  transcription  by binding  to  calcineurin,  a  cal- 
modulin-dependent protein phosphatase that is important in 
early T  cell activation  events (20,  21).  Therefore,  it could 
be expected that no single promoter element would be respon- 
sible for CsA activity. After transfection with IL-4 promoter 
deletion constructs, D10 cells were treated with 1 #M iono- 
mycin and 1 #g/ml CsA. In controls using comparable levels 
of ethanol  (vehicle for CsA) and ionomycin,  no effect was 
seen on induction relative to ionomycin alone (data not shown). 
In these experiments it was found that CsA could fully sup- 
press the inducible activity associated with any of the dele- 
tion constructs used (Fig.  3, A  and B). Indeed,  the effects 
of CsA were still apparent in the context of the first 77 bp 
of the IL-4 promoter (Fig. 3, A and B). CsA could also effec- 
tively suppress activation of the IL-4 promoter by Con A 
(Fig.  3 B). 
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from  -249 to  +6 bp of the IL-4 promoter deleting the 5' 
untranslated region. When this construct was transfected into 
D10 cells and induced with Con A, anti-CD3 or ionomycin 
promoter activity was retained  (Fig.  3 A). From these ex- 
periments  we can conclude  that the 5' untranslated  region 
is  not  necessary  for  activation  by Con  A,  anti-CD3,  or 
ionomycin. Also, CsA effectively  blocks induction in the con- 
text of this  construct. 
Mutagenesis of the IL-4 Promoter and Analysis of the Effects 
of Substitution Mutations on Inducible Promoter Function.  To 
define more precisely important cis-acting elements,  linker- 
scanning mutations were introduced into the IL-4 promoter 
by PCR. Each linker-scanning  mutation is 20 bp in length 
and lies within the context of the - 157 region (Fig. 4). Each 
base in the 20-bp stretch  was randomly mutated to one of 
the three remaining nucleotides. The mutation constructs were 
transfected into D10 cells and induced with the various agents 
as described above. In all experiments,  the plL4-157  wild- 
type construct was included  as an internal  control for fold 
induction levels. 
Results obtained with the mutation constructs emphasize 
the importance of the region  - 97 to  - 77 bp in Con A and 
anti-CD3 inducible IL-4 gene transcription.  Mut3 spans most 
of the region from  - 97 bp to - 77 bp of the IL-4 promoter. 
The region encompassing  mut3 is necessary for Con A and 
anti-CD3 induction based upon the deletion analysis (Fig. 
3 A). The region mutated in mut3,  however, is not solely 
responsible for induction through ConA or anti-CD3 be- 
cause mut4, mut9,  and mutl0 in the context of -157 bp, 
can also block this induction (Fig. 5, A and B). Other linker- 
scanning  mutations in the  -157 region (mutl  and mut2) 
were inducible by Con A and anti-CD3 (Fig. 5 A). There- 
fore, induction of IL-4 gene transcription by stimulation with 
Con A or anti-CD3 involves several sites spanning  the re- 
gion extending from  + 1 to  -97 bp. 
The sequences that control the response to ionomycin, how- 
ever, lie entirely within the first 77 bp of the IL-4 promoter. 
Linker-scanning  mutation analysis allowed us to localize the 
responsive element(s) to mut9 and mutl0 where fold induc- 
tion in response to ionomycin dropped to background levels 
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Figure 5.  Effect of linker-scanning mutations on inducible expression 
of Ib4 promoter constructs  in D10 calls. (A) Structure  of constructs  con- 
taining linker-scanning  mutations of the Ib4 promoter.  D10 cells were 
transfected with reporter phsmids and 24 h later stimulated with 10 #g/ml 
Con A, anti-CD3 coated plates, 1 #M ionomycin,  or 1 #g/ml CsA plus 
1 #M ionomycin. CAT activity was assayed 48 h after transfection.  Each 
plasmid was assayed in at least three independent  transfections.  The data 
is shown as mean fold induction  _+  SE. Fold induction was calculated 
as described in Fig. 3. The absolute percent  conversion was in the range 
of 2-15 % (*) Mean fold induction calculated from two experiments, where 
SE not shown. (B) Fold induction generated by linker-scanning mutations 
using Con A, anti-CD3, ionomycin,  or CsA plus ionomycin. 
(Fig. 5, A  and B). All other mutations in the  -157 region 
were inducible by ionomycin, including rout3 and rout4 (Fig. 
5, A  and B). 
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Figure  4.  Linker-scanning  mutagenesis  of the IL-4 promoter.  II.-4 5' flanking  sequence from  -140 to  -20 and specific nucleotide  substitutions 
are shown.  Substitution  mutations were made in the context of the plL4-157 construct.  All constructs  were verified by sequencing  of both strands 
1668  Transcription  of I1--4 Gene Is Regulated by Multiple Promoter Elements Figure 6.  Induction  of a heterologous promoter with I1r  5' sequences. D10 cells were transfected  with multiple copies of I1.,4 5' sequences in 
the pBLCAT2  vector which contains the bacterial tk promoter fused to the CAT gene. The cells were stimulated  24 h later with 10/zg/ml Con A, 
anti-CD3 coated  plates, 1 #M ionomycin, 1 #g/ml CsA plus 10/zg/ml Con A, 1 Izg/ml CsA plus plate-bound anti-CD3, or I #g/ml CsA plus 1 
/~M ionomycin.  CAT activity  was assayed  in three independent  experiments. A representative  experiment is shown. Fold  induction  was calculated  as 
described in Fig. 3. (A) D10 cells transfected  with three copies of the wild-type  rout4 region (20 bp) in the 5' to 3' orientation. (B) Three copies 
of the wild-type  rout4 region (20 bp) were transfected into D10 cells in the 3' to 5' orientation. (C) D10 cells transfected  with two copies of the 
wild-type rout9 plus 10 region (33 bp) in the 5' to 3' orientation. 
Two additional constructs were made, one that mutates 
sequences overlapping mut9 and mutl0, and another that mu- 
tated the putative TATA box. An 8-bp mutation, mutg/10, 
spanning bases  -43 to -35 of the IL-4 promoter completely 
abrogated the responses to Con A, anti-CD3, and ionomycin 
in D10 cells (Fig. 5, A  and B), thus defining more precisely 
a promoter element which plays a critical role in the induc- 
ible transcription of the IL-4 gene. Mutation of the TATA 
box also led to complete abolition of transcription (Fig. 5 A). 
Linker-scanning mutation constructs transfected into D10 
cells were induced with ionomycin or Con A in the presence 
of CsA. CsA was able to suppress  to background levels in- 
duced transcription from any linker-scanning mutant con- 
struct (Fig. 5 A). Therefore, we conclude that CsA can block 
the pathways arising from the T cell surface that are modu- 
lated by Con A  or ionomycin. 
Induction  of a  Heterologous Promoter  by  5'  IL-4  Gene  Se- 
quences.  To further confirm that specific IL-4 5' sequences 
contribute to IL-4 transcriptional regulation, heterologous 
promoter constructs were made. Sequences spanning regions 
that upon mutation showed a regulatory role in the IL-4 pro- 
moter were multimerized and placed upstream of the tk pro- 
moter in the pBLCAT2 vector.  Specifically, three copies  of 
IL-4 gene wild-type sequences corresponding to the mutated 
regions in mut3, mut4, mut9, and mutl0 were placed in the 
5' to 3' orientation upstream of tk promoter/CAT reporter 
gene sequences. An additional plasmid containing two copies 
of the region mutated by mut9 and mutl0 (-60 to  -28) 
was also constructed. 
Results utilizing multimerized sequences showed that the 
wild-type sequences spanning - 80 to - 60 bp (rout4 region) 
and - 60 to - 28 bp (rout9 plus mutl0 regions) were suffident 
to confer significant inducible expression upon the heterolo- 
gnus tk promoter. When sequences  -80 to  -60 bp were 
multimerized, placed upstream of the tk promoter, and trans- 
fected into D10 cells, they allowed the heterologous promoter 
to be induced by Con A and anti-CD3, as well as ionomycin 
(Fig.  6 A).  The induction was lower than that seen with 
the wild-type IL-4 promoter, but still significant. These se- 
quences could also mediate a response to Con A, anti-CD3, 
and ionomycin when multimerized and placed in the 3' to 
5' orientation in front of the tk promoter (Fig.  6 B). The 
inducible responses conferred on the tk promotor by the mul- 
timerized region - 80 to - 60 bp were completely suppressed 
by CsA (Fig.  6, A  and B). When the wild-type sequences 
encompassing  -60 to  -28 bp (rout9 plus mutl0 regions) 
were multimerized and transfected into D10 cells, inducible 
tk gene transcription by ionomycin was observed (Fig. 6 C). 
These sequences were also slightly responsive to Con A but 
not more than twofold above background transcription. No 
induction above basal transcription was seen using the stimulus 
anti-CD3 mAb. When multimerized, the region spanning 
the sequences  - 100 to  - 80 bp (rout3 region) could also in- 
crease the transcriptional response  of the heterologous pro- 
moter tk to Con A  and ionomycin (data not shown). Al- 
though measurable,  no more than twofold induction was 
achieved.  Sequences from  -60 to  -40  (rout9 region) and 
from  -40 to  -28  (mutl0 region) had no effect on the tk 
promoter when transfected into D10 cells and stimulated with 
the activating agents Con A or ionomycin (data not shown). 
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Figure 7.  IIr  5' region sequence  homology. Compar- 
isons of the murine 11:4 promoter with human, bovine, 
and rat I1:4 promoters are shown. The homologies  of the 
murine 1I.-4  promoter to the bovine, human, and rat were, 
respectively, 82% (103/125), 86% (135/157), and 93% 
(146/157). (Dark box) The region representing rout4 or 
the P element (34); (light box) 8-bp region represented  by 
rout9/10. 
Discussion 
In resting T  cells,  the IL-4 and IL-2 genes are quiescent. 
Upon occupancy of the TCR with its natural ligand  (an- 
tigen plus MHC) or an artificial  ligand, anti-CD3 mAb, or 
upon stimulation with calcium ionophores, T  cells become 
activated and IL-2 and IL-4 gene transcription is rapidly ini- 
tiated.  In contrast to IL-2 gene transcription  in Thl  cells, 
however, very little is known about how the signals trans- 
mitted through TCR occupancy lead to IL-4 gene transcrip- 
tion in Th2 cells. IL-4 regulatory sequences have not yet been 
defined, nor have the factors which bind these sequences been 
identified.  In this report, we have begun an analysis  of the 
murine  IL-4 promoter in Th2 cells  and have identified se- 
quences in the proximal promoter which mediate the response 
of Th2 cells to both TCIk crosslinking  and calcium iono- 
phore-dependent  signals. 
Initial experiments utilizing an IL-4 tk transgene demon- 
strated that 3 kb of upstream sequence is sufficient to achieve 
tissue-specific and inducible expression of the transgene  in 
a manner similar to the endogenous IL-4 gene. Specifically, 
the tissue distribution of tk mRNA in spleen, thymus, and 
LN mirrors endogenous IL-4 expression. Moreover, the trans- 
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gene promoter does not allow for expression in nonlymphoid 
tissues. TCR-mediated induction of IL-4 gene transcription 
also resides within this region, as evidenced by the induction 
of tk mRNA in anti-CD3  activated LN cells.  In the trans- 
genic mice, levels of tk message driven by 3 kb of the IL-4 
promoter are lower than endogenous IL-4. There are several 
possible explanations for this observation. It may be that the 
specific PCR primers used bind with higher affinity to their 
target sequences in the IL-4 cDNA than in the tk cDNA. 
Alternatively,  many reports exist showing that transgenes  may 
be expressed at higher or lower levels than the endogenous 
gene (22, 23). This phenomenon may depend on factors such 
as copy number or integration  site (24).  It is also possible 
that an enhancer exists elsewhere in the IL-4 gene, either fur- 
ther upstream of 3 kb or in an intron.  A recently published 
report,  however,  suggests that  there are no T  cell-specific 
enhancers located in IL-4 gene introns  (25). 
Deletional analysis established that sequences residing be- 
tween  -157  and  +6  bp  of the  IL-4  gene  confer  tissue 
specificity and inducibility on a CAT reporter gene in two 
different T  helper cells in vitro.  The D10 T  cell clone is a 
Transcription of II:4 Gene Is Regulated by Multiple Promoter Elements prototypic Th2 cell which secretes IL-4, IL-5, and IL-6 upon 
stimulation through the TCR. D10 cells require antigen plus 
APC stimulation to survive in tissue culture and fulfill the 
criteria for a nontransformed, growth factor-dependent T 
cell clone. EL4, on the other hand, is a T cell thymoma that 
secretes both IL-2 and IL-4 and,  therefore, cannot strictly 
be classified as either a Thl or Th2 cell. The deletion data 
demonstrate that fold induction varies little as sequences are 
removed from 3 kb to 801 bp and from 801 bp to 157 bp 
in D10 cells. Additional  deletional analysis through the re- 
gion -157 to  -77 bp further localized the active promoter 
to 97-bp upstream of the transcriptional start site. Sequences 
within this region are necessary for induction to occur after 
stimulation of the TCR-CD3 complex. However, there seems 
to be a divergence in the induction pathways for ionomycin 
and the TCR-CD3 complex.  This is shown by the ability 
of ionomycin to stimulate transcription  within the context 
of the  -77-bp promoter region whereas both Con A and 
anti-CD3 mAb require the 20 bp between  -97 and  -77. 
These results indicate that the major elements necessary for 
a minimal inducible promoter responsive to all T cell acti- 
vation signals tested lie within the first 97 bp of the IL-4 
promoter. 
Analysis using the linker-scanning mutants are in general 
agreement with the deletion mutants. Mut3, which spans 
most of the region between - 97 and - 77 bp, shows a sharp 
drop in its ability to be activated by Con A or anti-CD3. 
This mutation retains, however, the ability to be stimulated 
by ionomycin. This suggests that at least part of a c/s ele- 
ment necessary for IL-4 transcriptional  activation  through 
the TCR-CD3 complex lies within mut3. Examination  of 
this region revealed  no known promoter motifs. Furthermore, 
all of the mutations that disrupt sequences within the -77 
to + 58 bp promoter region also lack the capacity to respond 
to Con A or anti-CD3, including mut4, mut9, and mutl0. 
This data would suggest  that more than one cis element is 
necessary to generate a response to Con A or anti-CD3 as 
the mutated sequences span 80 bp. This is in contrast to a 
pathway dependent upon ionomycin which requires a smaller 
yet overlapping  region of the IL-4 promoter. Only the re- 
gion spanning rout9 and mutl0 (-60 to  -27 bp) is neces- 
sary for an ionomycin response. This suggests that the re- 
sponse  to  ionomycin may be limited to a single element 
spanning rout9 and rout10. Indeed, when 8 bp of the sequence 
spanning rout9 and mutl0 are mutated, the responses to Con 
A, anti-CD3, and ionomycin all decline to basal levels indi- 
cating that this 8-bp region plays a pivotal role in the induc- 
tion pathways leading to IL-4 gene transcription.  No known 
transcriptional elements were found to be homologous to the 
sequences in this region when a homology search was con- 
ducted. These data suggest that a transcription factor binding 
to the wild-type mutg/10 region may control the calcium- 
dependent response and is necessary along with other factors 
in controlling transcriptional responses originating from the 
TCR-CD3 complex which in D10 cells may be calcium in- 
dependent (26). 
Multimerization of the region spanning - 80 to  - 60 bp 
(rout4) led to a response to Con A and anti-CD3. This region 
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in conjunction with the regions mutated in rout3 and mut9/10 
mediates the response through the TCR, and is in fact a neces- 
sary part of this signal transduction pathway. When using 
the IL4-157 construct, the response to Con A was consis- 
tently severalfold  lower than the response to ionomycin. MUl- 
timerization of several IL-4 promoter regions led to lower 
fold induction versus fold induction achieved  when stimulating 
the wild-type construct. Therefore, it may not be possible 
in this system to measure the responses to Con A or anti- 
CD3 of  weaker promoter regions (such as rout3 and mutg/10) 
when they are muhimerized. The region spanning  mut4, 
however, is not necessary for the pathway dependent upon 
ionomycin as  demonstrated  by  the  mutational  analysis. 
Nevertheless, when the wild-type sequences corresponding 
to the mut4 region were muhimerized they did respond to 
ionomycin. When multimerized, the region encompassing 
sequences from -60 to -28 bp (rout9 plus mutl0) was also 
responsive to ionomycin and, to a lesser extent, to Con A. 
This is not surprising  in light of the results with rout9/10 
which demonstrated abolition of the transcriptional responses 
to both ionomycin and Con A. The region of the IL-4 pro- 
moter from -100 to  -80 bp (rout3 region) also showed a 
small yet consistent response to Con A and ionomycin. One 
interpretation of all these data might be that the regions mu- 
tated in mut4 and mut3 can moderate the calcium-dependent 
responses to ionomycin, but that the element identified by 
the rout9/10 mutation is both necessary and sufficient. The 
region represented by mut3 likely works in concert with the 
regions mutated in rout4 and mutg/10 to accomplish the tran- 
scriptional  response to TCR-mediated signals. 
T cell activation pathways leading from the cell surface to 
events in the nucleus are complex. Stimulation  through the 
TCR as accomplished by Con A or anti-CD3 forms one well- 
studied pathway (11). Other pathways that may intersect TCR- 
mediated pathways do exist. For example, treating T cells 
with calcium ionophores, such as ionomycin, leads to an influx 
of extracellular  calcium  into  the cell (11). This,  in  turn, 
influences downstream activation events. It has been postu- 
lated that increased intracellular calcium may be a necessary 
event in PKC activation through the TCR (27). Others, how- 
ever, postulate that calcium influx may actually trigger a dis- 
tinct TCR activation pathway (11). Increased calcium may 
be necessary at several steps in T cell activation.  However, 
there is no evidence that calcium is required for induction 
of IL-4 gene expression. In fact, certain Th2 clones, including 
D10,  do not flux calcium in response to TCR stimulation 
(28, 29). These clones, however, can still produce significant 
amounts oflL-4 upon TCR engagement (30). Our data would 
support at least some divergence between calcium-dependent 
and -independent pathways leading to IL-4 gene transcrip- 
tion. Recently, an alternative  pathway, involving the cell surface 
molecule CD28,  has been implicated  in T  cell activation 
(31-33).  Differential  activation  of these  various  signaling 
pathways could lead to distinctly different levels of IL-4 gene 
transcription.  Therefore, IL-4 production would be tightly 
regulated in different situations depending upon the activa- 
tion signals present. 
From an analysis of a combination of the deletion and mu- tation data, it becomes apparent that CsA is able to block 
transcription initiated through any positive promoter element. 
This inhibition also occurs with the combinations  of CsA 
with Con A or anti-CD3. CsA can completely  disrupt tran- 
scription even in the limited context of the first 77 bp of the 
IL-4 promoter. We have also found that CsA can inhibit in- 
ducible transcription in the limited context of the multimer- 
ized mut4 and mut9 plus 10 wild-type sequences. This indi- 
cates that CsA either acts directly upon trans-acting  factors 
binding to sequences  in these regions or that CsA affects  events 
at an earlier point in the T cell activation cascade. Recent 
evidence suggests that CsA acts upon calcineurin,  an early 
T  cell activation protein (20, 21). 
Using deletional and mutational analysis, two groups have 
identified elements important in the regulation of the human 
IL-4 promoter (34, 35). One element, the P element, lies 
within the region defined by our mut4 construct (34). This 
element was found to be responsive to PMA/calcium iono- 
phore. In our studies, mutation of this region does affect re- 
sponsiveness to Con A and anti-CD3 but not to ionomycin. 
However, when this region is fused to a heterologous  pro- 
moter it can respond to ionomycin as well as to Con A and 
anti-CD3. The combination of these data indicate that this 
region, containing the P element, is important in inducible 
IL-4 gene transcription.  Of interest, there is a perfect NFAT 
sequence within the mut4 region which we have recently 
found binds an inducible factor (Glimcher, L., unpublished 
data). Another group has identified two negative regulatory 
elements (NtLE-I and NRE-II) in the human IL-4 promoter 
(35). No evidence has been found for any functional negative 
regulatory regions in the analysis of the murine IL-4 pro- 
moter. Perhaps there may be subtle differences between the 
transcriptional  regulation of the human and mouse IL-4 
promoters, although the striking sequence  conservation (86%) 
in the region between -157 and  + 58 bp makes this rather 
unlikely (Fig. 7). Alternatively,  the discrepancies observed 
may be attributable  to the model system used. Both of the 
studies alluded to above have utilized the transformed T cell 
line Jurkat. Since this cell line produces very small quantities 
of IL-4, it was necessary in both reports to link IL-4 5' se- 
quences to a heterologous promoter.  This may complicate 
the analysis of additional regulatory signals on IL-4 gene tran- 
scription. Analysis of unmanipulated Th2 cell clones as per- 
formed here may give a more accurate representation of what 
occurs in vivo. 
Another group has defined an element in the GM-CSF 
promoter that shares homology  with human and murine IL-4 
promoter sequences  (36). This element, CLE0, binds a PMA/ 
A23187 inducible factor. We have mutated this element by 
linker-scanning mutagenesis (mut9). When this region is mu- 
tated, the IL-4 promoter loses inducible activity with Con A, 
anti-CD3, or ionomycin as compared with the wild-type pro- 
moter. Upon multimerization of the mut9 wild-type region, 
however, a heterologous promoter cannot be activated above 
basal transcription with Con A or ionomycin. This may in- 
dicate that the element identified in the GM-CSF promoter 
is not functional in the IL-4 promoter, or that it cannot act 
alone but requires other factors in the region to form a func- 
tional  complex. 
IL-2 is regulated by an enhancer-promoter complex that 
spans ~300 bp and that comprises several  promoter elements 
(10). Some of these elements are necessary whereas others 
are contributory to transcriptional  activation (8). Our data 
suggest that IL-4 is regulated in a similar manner. In the IL-4 
promoter, the wild-type region spanning  mut3 and mut4 
(-100  to  -60  bp)  is  clearly  important  for  a  calcium- 
independent response generated through the TCR-CD3 com- 
plex. This region contains one known functional element, 
the NFAT element, or the P element, and probably contains 
another element just upstream of the P element, This region, 
however, plays a minor role in the response to ionomycin. 
On the other hand, an element(s) that is mutated in rout9 
and mutl0 (-60 to  -24 bp) is necessary for any induced 
activity of the IL-4 promoter.  The IL-4 promoter also re- 
quires a TATA  box for transcription  to occur. One can envi- 
sion several promoter elements acting together, as in the IL- 
2 gene, in regulating IL-4 gene transcription.  Only one of 
the motifs identified in our analysis is homologous to ele- 
ments within the IL-2 enhancer complex. Unlike the IL-2 
gene, the transcription factors which bind IL-4 promoter ele- 
ments may also be regulated by divergent TCIL pathways. 
This would imply that the IL-4 and IL-2 genes are not regu- 
lated in a coordinate manner and that their actual promoter 
sequences, as well as alternative signaling pathways, play a 
pivotal role in establishing tissue-specific expression. It re- 
mains to be seen if transcription  factors that bind to these 
sequences are also unique. 
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